| Authors: |
Leung SOA; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, McGill University Health Center, Montreal, Quebec, Canada., Foley O; Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Harvard Medical School, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Chapel D; Department of Pathology, Michigan Medicine, University of Michigan, Ann Arbor, Michigan, USA., Da Silva A; Women's and Perinatal Pathology, Brigham and Women's Hospital, Harvard Medical School, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Nucci M; Women's and Perinatal Pathology, Brigham and Women's Hospital, Harvard Medical School, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Muto MG; Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Harvard Medical School, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Campos S; Department of Medical Oncology, Brigham and Women's Hospital, Harvard Medical School, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. |
